Atherosclerosis
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
2044
|
281
|
0.310 |
None |
1.000 |
1 |
|
2015 |
2015 |
Dyslipidemias
|
group |
Nutritional and Metabolic Diseases
|
Disease or Syndrome
|
471
|
184
|
0.310 |
None |
1.000 |
1 |
|
2018 |
2018 |
Atherogenesis
|
phenotype |
Cardiovascular Diseases
|
Pathologic Function
|
59
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Dyslipoproteinemias
|
phenotype |
Nutritional and Metabolic Diseases
|
Pathologic Function
|
24
|
|
0.300 |
None |
1.000 |
1 |
|
2018 |
2018 |
Alzheimer's Disease
|
disease |
Nervous System Diseases; Mental Disorders
|
Disease or Syndrome
|
3397
|
1843
|
0.120 |
None |
1.000 |
9 |
9
|
1993 |
2019 |
Chronic Lymphocytic Leukemia
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1447
|
291
|
0.100 |
None |
1.000 |
26 |
|
1989 |
2019 |
Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
10161
|
1644
|
0.100 |
None |
1.000 |
16 |
|
1990 |
2019 |
Malignant Neoplasms
|
group |
Neoplasms
|
Neoplastic Process
|
8621
|
1641
|
0.100 |
None |
1.000 |
12 |
2
|
1993 |
2019 |
High density lipoprotein measurement
|
phenotype |
|
Laboratory Procedure
|
545
|
1440
|
0.100 |
None |
1.000 |
2 |
3
|
2012 |
2019 |
Serum HDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
283
|
679
|
0.100 |
None |
1.000 |
1 |
1
|
2012 |
2012 |
Autoantibody measurement
|
phenotype |
|
Laboratory Procedure
|
27
|
52
|
0.100 |
None |
1.000 |
1 |
1
|
2009 |
2009 |
Serum total cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
486
|
1243
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Triglycerides measurement
|
phenotype |
|
Laboratory Procedure
|
563
|
1418
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Serum LDL cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
269
|
555
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Low density lipoprotein cholesterol measurement
|
phenotype |
|
Laboratory Procedure
|
483
|
1142
|
0.100 |
None |
1.000 |
1 |
2
|
2012 |
2012 |
Respiratory Tract Diseases
|
group |
Respiratory Tract Diseases
|
Disease or Syndrome
|
198
|
109
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Hodgkin Disease
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
900
|
148
|
0.090 |
None |
1.000 |
9 |
|
1994 |
2008 |
B-Cell Lymphomas
|
group |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1408
|
42
|
0.080 |
None |
1.000 |
8 |
|
1993 |
2019 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.060 |
None |
1.000 |
6 |
|
2003 |
2020 |
Malignant neoplasm of breast
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6941
|
3417
|
0.050 |
None |
1.000 |
5 |
|
1999 |
2016 |
B-CELL MALIGNANCY, LOW-GRADE
|
disease |
|
Neoplastic Process
|
350
|
19
|
0.050 |
None |
1.000 |
5 |
|
1990 |
2007 |
Primary malignant neoplasm
|
group |
Neoplasms
|
Neoplastic Process
|
8221
|
1374
|
0.050 |
None |
1.000 |
5 |
1
|
2013 |
2019 |
Ki-1+ Anaplastic Large Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
300
|
10
|
0.040 |
None |
1.000 |
4 |
|
2003 |
2005 |
Diffuse Large B-Cell Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
1043
|
127
|
0.040 |
None |
1.000 |
4 |
|
1990 |
2017 |
Breast Carcinoma
|
disease |
Neoplasms; Skin and Connective Tissue Diseases
|
Neoplastic Process
|
6776
|
2793
|
0.040 |
None |
1.000 |
4 |
|
1999 |
2016 |